Abstract
Prophylactic tetanus antitoxin is ineffective in the prevention of experimental tetanus. That this may be true clinically is indicated by the fact that there are increasing numbers of cases of tetanus in humans after prophylactic tetanus antitoxin. Despite this known ineffectiveness and the high rate of reaction to antitoxin (5 per cent), many physicians continue to use it prophylactically, apparently for medical legal reasons. Since tetanus in civilian wounds is so rare, occurring approximately once in every million wounds, the routine use of tetanus antitoxin will probably cause more harm than good.
It has been demonstrated experimentally that oxytetracycline is the most effective antimicrobial in the prevention of tetanus. It is, therefore, believed that adequate tetanus prophylaxis may be obtained by meticulous debridement and cleansing of the wound, by the administration of 1 gm. oxytetracycline daily for five days, and by intradermal administration of tetanus toxoid on the first, fourth and seventh days. Tetanus antitoxin is not given unless contaminated wounds have ben neglected for eight hours or more. In these instances, 15,000 units or more of tetanus antitoxin is given.
Tetanus toxoid remains the best wound prophylaxis and greater emphasis should be placed on immunizing entire populations.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANWAR A. A., TURNER T. B. Antibiotics in experimental tetanus; in vitro and in vivo studies. Bull Johns Hopkins Hosp. 1956 Feb;98(2):85–101. [PubMed] [Google Scholar]
- CONDIT P. K. Tetanus in California; epidemiology and a review of 232 cases. Calif Med. 1959 May;90(5):318–321. [PMC free article] [PubMed] [Google Scholar]
- FILLER R. M., ELLERBECK W. Tetanus prophylaxis. JAMA. 1960 Sep 3;174:1–4. doi: 10.1001/jama.1960.03030010003001. [DOI] [PubMed] [Google Scholar]
- HAMPTON O. P., Jr, HARD J. Active immunization against tetanus with intradermal toxoid. Surg Gynecol Obstet. 1959 Aug;109(2):223–224. [PubMed] [Google Scholar]
- LENNERT-PETERSEN O. The effect of chlorotetracycline and oxytetracycline on Cl. tetani in vitro and in vivo. Acta Pathol Microbiol Scand. 1954;35(6):591–598. doi: 10.1111/j.1699-0463.1954.tb00907.x. [DOI] [PubMed] [Google Scholar]
- MARTINI M. M. Prophylactic failure of 1,500 units of tetanus antitoxin; a report of two cases. Calif Med. 1955 Mar;82(3):189–191. [PMC free article] [PubMed] [Google Scholar]
- REISMAN R. E., ROSE N. R., ARBESMAN C. E. Immunologic studies of serum sickness from bovine antitetanus toxin. JAMA. 1961 Jun 24;176:1004–1008. doi: 10.1001/jama.1961.03040250030010. [DOI] [PubMed] [Google Scholar]
- RUEGSEGGER J. M. Further observations on the permanence of tetanus antitoxin. Arch Intern Med. 1960 Sep;106:410–416. doi: 10.1001/archinte.1960.03820030098015. [DOI] [PubMed] [Google Scholar]
- STOLLERMAN G. H., RUSOFF J. H. Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new repository penicillin preparation. J Am Med Assoc. 1952 Dec 20;150(16):1571–1575. doi: 10.1001/jama.1952.03680160021005. [DOI] [PubMed] [Google Scholar]
- TAYLOR W. I., NOVAK M. Prophylaxis of tetanus with penicillin-procaine. Ann Surg. 1951 Jan;133(1):44–49. doi: 10.1097/00000658-195101000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TOOGOOD J. H. Allergic reactions to antitetanus serum. Can Med Assoc J. 1960 Apr 30;82:907–912. [PMC free article] [PubMed] [Google Scholar]